BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34848359)

  • 1. Systematic characterization of the metabolites of defatted walnut powder extract in vivo and screening of the mechanisms against NAFLD by UPLC-Q-Exactive Orbitrap MS combined with network pharmacology.
    Ren SM; Zhang QZ; Jiang M; Chen ML; Xu XJ; Wang DM; Pan YN; Liu XQ
    J Ethnopharmacol; 2022 Mar; 285():114870. PubMed ID: 34848359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-NAFLD effect of defatted walnut powder extract in high fat diet-induced C57BL/6 mice by modulating the gut microbiota.
    Ren SM; Zhang QZ; Chen ML; Jiang M; Zhou Y; Xu XJ; Wang DM; Pan YN; Liu XQ
    J Ethnopharmacol; 2021 Apr; 270():113814. PubMed ID: 33444725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zhisou powder displays therapeutic effect on chronic bronchitis through inhibiting PI3K/Akt/HIF-1α/VEGFA signaling pathway and reprograming metabolic pathway of arachidonic acid.
    Dong Y; Liu Y; Tang J; Du J; Zhuang X; Tan S; Yang Y; Yin D
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117110. PubMed ID: 37673198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the active compounds and potential mechanism of the anti-nonalcoholic fatty liver disease activity of the fraction from Schisandra chinensis fruit extract based on multi-technology integrated network pharmacology.
    Li B; Xiao Q; Zhang J; Wang Y; Liu J; Zhang B; Liu H
    J Ethnopharmacol; 2023 Jan; 301():115769. PubMed ID: 36183952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective mechanisms of defatted walnut powder against scopolamine-induced Alzheimer's disease in mice revealed through metabolomics and proteomics analyses.
    Xu X; Ding Y; Liu M; Zhang X; Wang D; Pan Y; Ren S; Liu X
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117107. PubMed ID: 37652196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats.
    Pan M; Deng Y; Qiu Y; Pi D; Zheng C; Liang Z; Zhen J; Fan W; Song Q; Pan J; Li Y; Yan H; Yang Q; Zhang Y
    Phytomedicine; 2024 Jul; 130():155712. PubMed ID: 38763008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic characterization of the absorbed components of Ligustri Lucidi Fructus and their metabolic pathways in rat plasma by ultra-high-performance liquid chromatography-Q-Exactive Orbitrap tandem mass spectrometry combined with network pharmacology.
    Zhang D; Xiong L; Fang L; Li H; Zhao X; Luan R; Zhao P; Zhang X
    J Sep Sci; 2021 Dec; 44(24):4343-4367. PubMed ID: 34687589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and mechanism prediction of mulberroside A metabolites
    Zhang X; Dong P; Song J; Zhang H; Wang F; Liu Y; Yan Y; Li L
    Front Chem; 2022; 10():981173. PubMed ID: 36238092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying potential active components of walnut leaf that action diabetes mellitus through integration of UHPLC-Q-Orbitrap HRMS and network pharmacology analysis.
    Liu R; Su C; Xu Y; Shang K; Sun K; Li C; Lu J
    J Ethnopharmacol; 2020 May; 253():112659. PubMed ID: 32058009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated network pharmacology, metabolomics, and transcriptomics of Huanglian-Hongqu herb pair in non-alcoholic fatty liver disease.
    Zhang X; Zhang J; Zhou Z; Xiong P; Cheng L; Ma J; Wen Y; Shen T; He X; Wang L; Zhang Y; Xiao C
    J Ethnopharmacol; 2024 May; 325():117828. PubMed ID: 38325669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the chemical constituents and mechanism of Kai-Xin-San based on UPLC-Q-Exactive MS and network pharmacology.
    Shang B; Jia S; Zhang T; Gao F; Lu M; Chen K; Jiao J; Dai Z; Zeng Q; Xu B; Lei H
    J Ethnopharmacol; 2024 Mar; 322():117652. PubMed ID: 38151178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors.
    Nie H; Deng Y; Zheng C; Pan M; Xie J; Zhang Y; Yang Q
    J Cell Mol Med; 2020 May; 24(9):5168-5184. PubMed ID: 32189432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification.
    Wu Z; Jia M; Zhao W; Huang X; Yang X; Chen D; Qiaolongbatu X; Li X; Wu J; Qian F; Lou Y; Fan G
    J Ethnopharmacol; 2022 May; 289():115031. PubMed ID: 35091014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolites Identification and Mechanism Prediction of Neobavaisoflavone In Vitro and In Vivo of Rats through UHPLC-Q-Exactive Plus Orbitrap MS Integrated Network Pharmacology.
    Li L; Dong F; Wang B; Song J; Zhang H; Wang P; Wang F; Yan Y; Zhang X
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic investigation for the mechanisms and the substance basis of Yang-Xin-Ding-Ji capsule based on the metabolite profile and network pharmacology.
    Wu Y; Qiu Z; Ren B; Sui F
    Biomed Chromatogr; 2021 Dec; 35(12):e5202. PubMed ID: 34145910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of
    Luo Z; Liu Y; Han X; Yang W; Wang G; Wang J; Jiang X; Sen M; Li X; Yu G; Shi Y
    Front Nutr; 2021; 8():677659. PubMed ID: 34604271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UPLC-Q-TOF/MS-based screening and identification of two major bioactive components and their metabolites in normal and CKD rat plasma, urine and feces after oral administration of Rehmannia glutinosa Libosch extract.
    Tao JH; Zhao M; Wang DG; Yang C; Chen GT; Zhao X; Pu XL; Jiang S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():98-106. PubMed ID: 26262601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective substances and molecular mechanisms guided by network pharmacology: An example study of Scrophulariae Radix treatment of hyperthyroidism and thyroid hormone-induced liver and kidney injuries.
    Sheng MY; Peng DW; Peng HM; Zhang YL; Xiao L; Zhang MR; Wang SY; Zhao CP; Zhu SY; Lu JK; Lin L; Huang R; Nie J; Fang JB
    J Ethnopharmacol; 2024 May; 326():117965. PubMed ID: 38423410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering anti-benign prostatic hyperplasia potential of liangwanoside II based on metabolite profile characterization combined with targeted network pharmacology.
    Fan L; Peng Y; Sun C; Ma P; Peng C; Sun A; Li X
    J Ethnopharmacol; 2023 Nov; 316():116725. PubMed ID: 37271331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.